World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
17628
World Ranking
15826
National Ranking
16

Rana P. Singh publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Rana P. Singh sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 234 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Rana P. Singh D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Rana P. Singh sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Rana P. Singh is affiliated with Jawaharlal Nehru University in India and has contributed extensively to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research spans multiple subfields including Molecular Biology, Oncology, Plant Science, Pharmacology, and Pulmonary and Respiratory Medicine.

Their scholarly output includes numerous publications in well-regarded venues, including:

  • Cancer Research
  • Cureus
  • Journal of Cancer Prevention
  • Molecular Carcinogenesis
  • Life Sciences

Singh's main topics of research focus on Nanoparticles: synthesis and applications, Cell death mechanisms and regulation, Cancer Cells and Metastasis, PARP inhibition in cancer therapy, Algal biology and biofuel production, Garlic and Onion Studies, and Spaceflight effects on biology.

Among Singh's recent papers are:

  • "Therapeutic application of Carica papaya leaf extract in the management of human diseases," published in 2020 in DARU Journal of Pharmaceutical Sciences
  • "Silver Nanoparticles Synthesized Using Carica papaya Leaf Extract (AgNPs-PLE) Causes Cell Cycle Arrest and Apoptosis in Human Prostate (DU145) Cancer Cells," published in 2020 in Biological Trace Element Research
  • "Green Synthesis of Silver Nanoparticles Using the Tridax procumbens Plant Extract and Screening of Its Antimicrobial and Anticancer Activities," published in 2022 in Oxidative Medicine and Cellular Longevity
  • "Therapeutic potential of biogenic and optimized silver nanoparticles using Rubia cordifolia L. leaf extract," published in 2022 in Scientific Reports
  • "Cytotoxic, Antimitotic, DNA Binding, Photocatalytic, H2O2 Sensing, and Antioxidant Properties of Biofabricated Silver Nanoparticles Using Leaf Extract of Bryophyllum pinnatum (Lam.) Oken," published in 2021 in Frontiers in Molecular Biosciences

Frequent coauthors in Singh's publications include:

  • Sivapar V. Mathan
  • Ragini Singh
  • Deepali Mishra
  • Mansoor Ali
  • Arshad Jamal

Best Publications

  • Hazardous effects of chemical pesticides on human health-Cancer and other associated disorders.

    Akash Sabarwal;Kunal Kumar;Rana P. Singh

  • Anticancer potential of silymarin: from bench to bed side.

    Rajesh Agarwal;Charu Agarwal;Haruyo Ichikawa;Rana P. Singh

  • Silibinin Strongly Synergizes Human Prostate Carcinoma DU145 Cells to Doxorubicin-induced Growth Inhibition, G2-M Arrest, and Apoptosis

    Anil K Tyagi;Rana P Singh;Chapla Agarwal;Daniel C F Chan

  • Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.

    Chapla Agarwal;Rana P Singh;Sivanandhan Dhanalakshmi;Anil K Tyagi

  • A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells.

    Dongsool Yim;Rana P Singh;Chapla Agarwal;Sookyeon Lee

  • Dietary Feeding of Silibinin Inhibits Advance Human Prostate Carcinoma Growth in Athymic Nude Mice and Increases Plasma Insulin-like Growth Factor-binding Protein-3 Levels

    Rana P. Singh;Sivanandhan Dhanalakshmi;Anil K. Tyagi;Daniel C. F. Chan

  • Silymarin and silibinin cause G1 and G2–M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin

    G Deep;R P Singh;C Agarwal;D J Kroll

  • Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells.

    Ravikanth Veluri;Rana P. Singh;Zhengjie Liu;John A. Thompson

  • Grape Seed Extract Inhibits In vitro and In vivo Growth of Human Colorectal Carcinoma Cells

    Manjinder Kaur;Rana P. Singh;Mallikarjuna Gu;Rajesh Agarwal

  • Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin-like growth factor binding protein-3.

    Rana P. Singh;Anil K. Tyagi;Sivanandhan Dhanalakshmi;Rajesh Agarwal

  • Synergistic anti-cancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells.

    Girish Sharma;Anil K. Tyagi;Rana P. Singh;Daniel C.F. Chan

  • Phytochemicals as cell cycle modulators--a less toxic approach in halting human cancers.

    Rana P. Singh;Sivanandhan Dhanalakshmi;Rajesh Agarwal

  • Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome c release

    Chapla Agarwal;Rana P. Singh;Rajesh Agarwal

  • Flavonoid antioxidant silymarin and skin cancer.

    Rana P. Singh;Rajesh Agarwal

  • Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis.

    S Dhanalakshmi;R P Singh;C Agarwal;R Agarwal

  • Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis.

    Rana P. Singh;Mallikarjuna Gu;Rajesh Agarwal

  • Silibinin Inhibits Established Prostate Tumor Growth, Progression, Invasion, and Metastasis and Suppresses Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Transgenic Adenocarcinoma of the Mouse Prostate Model Mice

    Rana P. Singh;Komal Raina;Girish Sharma;Rajesh Agarwal

  • Tumor angiogenesis--a potential target in cancer chemoprevention.

    Tariq A. Bhat;Rana P. Singh

  • Effect of Silibinin on the Growth and Progression of Primary Lung Tumors in Mice

    Rana P. Singh;Gagan Deep;Manesh Chittezhath;Manjinder Kaur

  • Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy.

    Rana P Singh;Sivanandhan Dhanalakshmi;Chapla Agarwal;Rajesh Agarwal

Frequent Co-Authors

Rajesh Agarwal
Rajesh Agarwal University of Colorado Anschutz Medical Campus
Gagan Deep
Gagan Deep Wake Forest University
Shivendra V. Singh
Shivendra V. Singh University of Pittsburgh
Alvin M. Malkinson
Alvin M. Malkinson University of Colorado Denver
Kapaettu Satyamoorthy
Kapaettu Satyamoorthy Manipal University Jaipur
Kumarasamy Thangaraj
Kumarasamy Thangaraj Centre for DNA Fingerprinting and Diagnostics
Keshav K. Singh
Keshav K. Singh University of Alabama at Birmingham
Michael Pollak
Michael Pollak McGill University
Sudhakar Srivastava
Sudhakar Srivastava Banaras Hindu University
Lingaraj Sahoo
Lingaraj Sahoo Indian Institute of Technology Guwahati

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online options can broaden your career prospects in medicine and healthcare. Flexible learning makes it easier for busy students and working professionals to further their education and enter specialized roles more quickly.

For those seeking advanced practice, the cheapest dnp programs provide a pathway to leadership positions in nursing at a competitive cost. If you’re looking for a shorter route into nursing, lpn online programs offer fast-track options that prepare you for entry-level nursing positions.

Mental health specialties are also growing. With online psych np programs, you can train to become a psychiatric nurse practitioner—providing essential care for diverse communities. Additionally, those interested in healthcare leadership or administration can find affordable options through the cheapest online health science degree.

Choosing the right online degree depends on your career interests, budget, and desired pace. Each of these pathways supports future growth and flexibility in the dynamic field of healthcare.

Best Scientists Citing Rana P. Singh

Trending Scientists

Recently Published Articles